STAT

Experimental TB vaccine shows promise in clinical trials

As world leaders pledged support for the fight against tuberculosis at the United Nations, some good news in the effort nearly slipped under the radar.
A child is given a new TB vaccine as part of a clinical trial in South Africa in 2011. Source: RODGER BOSCH/AFP/Getty Images

As world leaders pledged support for the fight against tuberculosis at the United Nations this week, some good news in the effort to develop weapons to combat the bacterium nearly slipped under the radar.

An experimental TB vaccine showed solid protection in a clinical trial reported Tuesday in the New England Journal of Medicine. The vaccine is being developed by GSK and , a nonprofit organization working on affordable tuberculosis vaccines.

You're reading a preview, sign up to read more.

More from STAT

STAT7 min read
Inhumane Or Unavoidable? As Congress Scrutinizes An Increase In Monkey Research, Scientists Defend Its Necessity
Scientists are relying on monkey research more than ever before. And now Congress wants the NIH and FDA to explain why.
STAT6 min readSociety
Opinion: Combatting Misinformation On Biosimilars And Preparing The Market For Them Can Save The U.S. Billions
For more than a decade, biosimilars have flourished in Europe. That hasn't happened in the U.S. because of misinformation and poor market preparation.
STAT3 min readPolitics
With Eyes On Gilead, Lawmakers Want Details On How HHS Reviews Possible Patent Infringement
After a ruckus over a pricey Gilead Sciences drug for HIV, lawmakers want details on how HHS reviews possible patent infringement.